Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
about
Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a reviewΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Hepatitis C virus infection and dialysis: 2012 update.Management of hepatitis C in patients with chronic kidney disease.Hepatitis C and kidney disease: An overview and approach to management.Management of the kidney transplant patient with chronic hepatitis C infectionEfficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus InfectionSASLT practice guidelines: management of hepatitis C virus infection.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Hepatitis C virus infection and kidney transplantation in 2014: what's new?Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States.Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure.What are the management issues for hepatitis C in dialysis patients?: management of hepatitis C infection in kidney transplant candidates.What are the management issues for hepatitis C in dialysis patients?: hepatitis C virus infection and its treatment in patients with end-stage renal disease.Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.Viral hepatitis in solid organ transplantation.Recommendations for the treatment of hepatitis C virus infection in chronic kidney disease: a position statement by the Spanish association of the liver and the kidney.Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity.Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.Viral hepatitis in hemodialysis: An update
P2860
Q26821786-0105E991-5693-48BB-8129-0C73D16357B3Q26864647-D944086D-5ACA-4603-96ED-7E431107B68FQ30355190-67D81795-1254-4FDF-A64F-6EE5CC75C3B7Q30417045-754CFDE0-0BC5-484A-B3B7-7C9505040F9FQ33710828-CCF28C3F-345B-4B18-91A8-48B90769AD60Q34932338-BBEF8E39-E4F0-4C97-9180-2EDF84089AC7Q34966853-6E1B5264-86D6-44F6-8B94-30EB7B3DE80DQ34988932-406C5A10-CB6C-4A48-B051-2056FE601369Q36077546-55F8569E-A844-4949-BC70-7D2BCA1C79C5Q37019765-CD8F12DF-5460-4EFD-8556-94F5889EF4BDQ38213956-819059BC-AF6D-4BD6-915D-81DE1B1411A9Q38236820-4C545B93-B24C-45FD-99C2-09F8E0CE20D5Q39102936-EAB09522-9214-4F10-B96C-615499A4B3FBQ40107697-968D01C1-77C3-44B6-A677-7E7BC8E75CE3Q40476119-67D8FADF-DE18-4829-813E-40F5452FBE10Q41745939-1472A55A-C5CD-41B9-AB19-F7E79AFDE37BQ41745947-8D71E638-8922-48C0-889B-7645589CC9E3Q42223532-5147C851-6F01-476C-8CAF-4F12ACB80439Q42272319-8DB1FA64-E3E6-46CA-B516-97499AFCE3B9Q45325791-A3F8D097-84E0-458C-9E26-AC5E89895576Q46661989-F65D3451-9819-403D-B311-4631AB6AF0FBQ52653977-CD7FA3FC-553C-407B-9280-54BD84FDE000Q56896375-B9199874-0F4B-4F06-9411-38C970B2B41C
P2860
Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Combined antiviral therapy of ...... a-analysis of clinical trials.
@en
Combined antiviral therapy of ...... a-analysis of clinical trials.
@nl
type
label
Combined antiviral therapy of ...... a-analysis of clinical trials.
@en
Combined antiviral therapy of ...... a-analysis of clinical trials.
@nl
prefLabel
Combined antiviral therapy of ...... a-analysis of clinical trials.
@en
Combined antiviral therapy of ...... a-analysis of clinical trials.
@nl
P2093
P2860
P921
P1476
Combined antiviral therapy of ...... a-analysis of clinical trials.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2010.01405.X
P577
2010-11-25T00:00:00Z